Weill Cornell Medicine

Weill Cornell Medicine is a top-ranked academic medical institution that, in addition to its primary mission of education and research, operates a comprehensive innovation ecosystem called Enterprise Innovation. This arm is dedicated to translating scientific discoveries into new healthcare solutions and commercial ventures. Through programs like the BioVenture eLab, the Daedalus Fund for Innovation, and the Enterprise Innovation Catalyst Fund, it provides funding, mentorship, and resources to foster startups and de-risk early-stage technologies to make them attractive for external investors and industry partners. As of FY2024, its affiliated startups had cumulatively raised $2.13 billion.